Three experiments were conducted to evaluate elevated dietary NaCl levels as a means of offsetting industry-observed reductions of growth, feed intake, and feed efficiency associated with early (35-d) coccidiostat withdrawal. In the first experiment, monensin (100 ppm) was withdrawn and dietary salt levels of 0.33, 0.48, 0.63, 0.78, or 0.93% provided from 35 to 42 d of age. Experiments 2 and 3 involved lasalocid (110 ppm) withdrawal and salt amounts of 0.33, 0.53, 0.73, or 0.93%. In all studies, a positive control of 0.33% salt and the coccidiostat was also given.
INTRODUCTION
Field observations by Florida broiler production personnel indicated that the early withdrawal of a coccidiostat (100 ppm lasalocid) at 35 d for economic reasons resulted in an immediate 14% reduction of water intake, reduced growth rate, and poorer feed efficiency.
Data collected from previous research studies concerning performance after coccidiostat withdrawal have been inconsistent and somewhat in contrast to the above observations. McDougald and McQuistion (1980) indicated that an increase in feed intake and weight gain was commonplace in the industry after monensin withdrawal. Compensatory growth occurred during the withdrawal period after monensin (McDougald and McQuistion, 1980; Metzler et al., 1987) or salinomycin (McDougald et al., 1981) withdrawal. On the other hand, neither Diambra et al. (1991) nor Chapman et al. (1993) demonstrated a growth improvement after salinomycin withdrawal from the diet. The latter paper did report a depression of feed consumption during the medicated period and a subsequent increase during the withdrawal period.
Some coccidiostats have been suspected of stimulating water consumption and causing litter moisture problems, but there is limited scientific support for this notion. Radu et al. (1987) found in a 49-d study that control groups not receiving medication drank more than birds receiving 60 ppm salinomycin in the feed. Wheelhouse et al. (1985a) used that same drug level and reported a significant reduction of water intake at 28 d; however, the effect disappeared by 56 d. Although water intake values reported by Wheelhouse et al. (1985b) were significantly increased for lasalocid over those for monensin groups, neither differed from unmedicated groups or those receiving salinomycin. In 21-d battery experiments with several coccidiostats supplemented at intermediate or maximum approval levels, Damron (1994) found that lasalocid significantly increased daily water intake over that of unmedicated controls. In 42-d studies by Ouart et al. (1995) , dietary lasalocid was also found to result in elevated 21-and 42-d water consumption. Litter moisture was higher at 21 d for lasalocid-fed groups, but this difference had disappeared by 42 d.
A review of the literature did not find research designed to answer the question of improving performance during the drug withdrawal period; therefore, because salt is well recognized as an enhancer of fluid intake, these studies were initiated to explore the use of elevated dietary salt levels as a means of improving 
MATERIALS AND METHODS
Three experiments were conducted with commercial broilers (Arbor Acres 2 in Experiment l; Ross 3 × Avian 4 for Experiments 2 and 3) subjected to early coccidiostat withdrawal at 35 d of age. At 35 d, diets were fortified with a graded series of salt levels to ascertain whether feed intake, and, subsequently growth rate, could be enhanced in the postmedication period. Water consumption was also determined after 35 d in Experiments 2 and 3. In each experiment, the starter diet (Table 1) was given for the first 21 d of age followed by a growerfinisher (Table 1 ) through 42 d. At 35 d the growerfinisher diet was modified without alteration of nutrient content by manipulating the level of filler (builder's sand) to accommodate alterations of coccidiostat and salt inclusion levels. Six treatments were involved in Experiment 1. Salt levels ranged from 0.33 to 0.93% in increments of 0.15%, with an additional positive control group being given 0.33% salt and the continued coccidiostat. Experiments 2 and 3 utilized five treatments consisting of salt amounts varying from 0.33 to 0.93% in 0.20% increments along with the positive control of continued coccidiostat and 0.33% salt. Coccidiostats were monensin (100 ppm) in Experiment 1 and lasalocid (110 ppm) for the latter two trials.
Birds in all three experiments were grown in floor pens (1.8 × 3.7 m) on peanut shell litter with feed and water supplied for ad libitum consumption. New litter was used in Experiment 1, and Experiments 2 and 3 were started on used litter topdressed with fresh peanut hulls. Brooding was accomplished with two infrared lamps per pen, suspended 40.6 cm above the litter, and birds were allowed to find their comfort zone by moving in or out of the heated area. Tap water was provided using one bell drinker per pen. In Experiments 2 and 3, this drinker was connected to an overhead 20-L plastic container, which was weighed at 35 and 42 d of age in order to calculate water consumption by difference. Mortality was not treatment related and therefore, has not been presented. Six replicate pens of 72 straight-run broilers received each treatment in Experiment 1, and five replicate pens of 60 birds were assigned each diet in the latter two studies.
Significant differences were determined by analysis of variance according to Snedecor and Cochran (1967) , and differences among treatment means were identified by Duncan's multiple range test (1955) .
RESULTS AND DISCUSSION
Regardless of salt level, the removal of monensin from the broiler's diet between 35 and 42 d of age resulted in significantly lower body weight gains ( Table  2 ). The addition of incremental levels of dietary salt did not improve body weight gain significantly when compared to controls. Feed conversion values were significantly improved by dietary salt levels above 0.63% when compared to the lower levels of supplementation without monensin. Birds fed the two higher levels of salt, 0.78 and 0.93% had feed conversion values not significantly different from the group for which monensin was continued along with 0.33% salt. Feed intake was significantly lower for the 0.78% salt treatment than for all but the 0.48% group. This is not felt to be a real Neither the continued presence of lasalocid in the diet during the last week nor increasing salt concentrations affected body weight gain during that period in Experiment 2 (Table 3) . Feed intake was greater for the unmedicated group receiving a normal salt level (0.33%) than for other treatments. Feed consumption was not influenced by increasing salt. Feed conversion was significantly improved by increased salt levels. As might be expected, water intake increased with dietary salt, but the presence or absence of lasalocid did not influence water consumption.
Results of Experiment 3 (Table 4) were similar to those of Experiment 2 in regard to weight gain; however, in this study, feed intake and feed conversion were not influenced by the feeding of lasalocid or elevated salt levels in the absence of medication. Again, water intake paralleled increasing dietary salt but was not altered by the presence or absence of lasalocid.
These results are in contrast to those reported through field observations by a commercial broiler company in Florida. No reductions in body weight gain, water intake, feed consumption, or feed efficiency were observed when lasalocid was withdrawn early as an economy measure. In the lasalocid studies, increasing salt levels did have the expected affect of increasing water consumption but feed intake was not improved. These differences may have been at least partially due to differences in coccidiosis challenge between industry and research environments.
Withdrawal of monensin 1 wk before slaughter was associated with reduced body weight gain, which was not significantly improved by salt addition. However, feed efficiency was improved to the level of the group receiving continued medication by salt amounts of 0.78% and above. Elevated dietary salt levels do not appear to be a reliable means of offsetting reduced performance related to early coccidiostat withdrawal, nor were such performance problems demonstrated for lasalocid in these trials.
